ClinicalTrials.gg
CompletedNCT07926464Updated Nov 9, 2026

Laparoscopic Transabdominal Preperitoneal Technique in Repair of Recurrent Inguinal Hernia

An interventional study of Laparoscopic Transabdominal Preperitoneal Technique in Laparoscopic, Transabdominal Preperitoneal and Repair, sponsored by Port Said University hospital. Completed at 1 site in Egypt. Open to participants aged 20 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-09.

Primary conditionHernia, InguinalRegistry: RecurrenceReclassifiedWhy we changed it
Registry
Recurrence — the first condition term the registry derived for this study.
ClinicalTrials.gg
Hernia, Inguinal
Why
  1. Recurrence describes something many studies share rather than a condition a study is about.
  2. The study's listed conditions name Hernia, Inguinal.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Port Said University hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 11 months after the study started (first participant enrolled Dec 2024, registered Nov 2026).
Updated Nov 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Not applicable
Ages
20 Years to 65 Years
Sex
All
01

Study summary

This study aimed to evaluate feasibility and safety of laparoscopic repair of recurrent inguinal hernia transabdominal preperitoneal technique as regard operative time, hospital stay, postoperative complications and recurrence rate.

Read the detailed description

Among hernias, inguinal hernias are the most prevalent; one-third of males will have this condition. Weak abdominal transverse tissue at the myopectineal aperture is the root cause of all three types of hernias: direct inguinal, oblique, and femoral.

All three types of hernias-inguinal, straight, and femoral-can be treated simultaneously with a single-side repair of the myopectineal aperture. Adults undergoing laparoscopic surgery for an abdominal hernia may also benefit from this procedure. The preperitoneal retropubic space and the extraperitoneal space are non-natural areas that may be found under the lower front wall of the abdomen. The peritoneum and the shallow transverse tissue both contain them. In order to fix an inguinal hernia using laparoscopy, a firm split is used.

Postoperative discomfort and soreness affect a large percentage of patients. People who were very young or who had severe groin pain before to surgery are more likely to have this. In order to rule out a recurrence of the hernia, a thorough evaluation is necessary in these patients, and an MRI is often performed.

02

Conditions studied

  • Laparoscopic
  • Transabdominal Preperitoneal
  • Repair
  • Recurrent
  • Inguinal Hernia

Browse trials for

03

In context

Hernia, Inguinal Reclassified

543 studies on the registry are indexed under Hernia, Inguinal; 92 are open to participants now.

This study's enrollment of 31 is below the median of 90 across 395 interventional studies indexed under Hernia, Inguinal.

Browse Hernia, Inguinal studies →

Lead sponsor

Port Said University hospital is the lead sponsor of 6 studies on the registry; none are open to participants now.

Compared within Hernia, Inguinal, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Recurrence. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
20 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age from 20 to 65 years old
  • Both genders
  • unilateral and bilateral recurrent inguinal hernias

Exclusion criteria

Exclusion Criteria:

  • Primary inguinal hernia.
  • III or beyond.
  • Major abdominal surgery.
  • Morbid obesity with (BMI) more than 40 kg/m2.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
31 participants (actual)

Study arms

  • Experimental
    Study group

    Patients with unilateral or bilateral recurrent inguinal hernia.

    Procedure: Laparoscopic Transabdominal Preperitoneal Technique

Interventions

  • ProcedureLaparoscopic Transabdominal Preperitoneal Technique

    Patients underwent laparoscopic transabdominal preperitoneal technique for recurrent inguinal hernia.

06

What researchers measure

Primary outcomes

  1. Incidence of postoperative complications

    Incidence of postoperative complications such as seroma, mesh rejection, urinary retention, subcutaneous emphysema, groin pain, wound infection, and recurrence were recorded.

    Time frame: 12 months post-procedure

Secondary outcomes

  1. Degree of patient's satisfaction

    Cosmetic outcome was analyzed using the patient's satisfaction score, which was assessed by the verbal rating scale: 0 = not at all, 1 = poorly satisfied, 2 = average satisfaction, and 3 = good satisfaction.

    Time frame: 12 months post-procedure

07

Study locations

1 site
  • Port Said University
    Port Said, 42526, Egypt
08

References and documents

Individual participant data

Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Supporting information: Study protocol

Time frame: After the end of study for one year.

Access criteria: The data will be available upon a reasonable request from the corresponding author.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2024 to primary completion in Nov 2025, 11 months.

Of 177 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's 11 months is below that.

Counting every sponsor, half of 186 studies reached it within 19 months; a quarter within 9 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2026
First posted
Nov 9, 2026
StartActual
Dec 1, 2024
Primary completionActual
Nov 1, 2025
CompletionActual
Nov 1, 2025
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07926464
Lead sponsor
Port Said University hospital
Responsible party
Mohamed AbdElhamid Tobgy (General Surgery Department, Faculty of Medicine, Misr University for Science and Technology, Giza, Egypt, Port Said University hospital) — Principal investigator
First posted
Nov 9, 2026
Start date
Dec 1, 2024
Primary completion
Nov 1, 2025
Completion
Nov 1, 2025
Last update
Nov 9, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion